-
1دورية أكاديمية
المؤلفون: Zhi Shan, Lijie Qiu, Huihua Chen, Jingshen Zhou
المصدر: Buildings, Vol 13, Iss 9, p 2178 (2023)
مصطلحات موضوعية: bridge construction, risk factors, coupling analysis, N-K random Boolean network model (N-K model), social network analysis (SNA), Building construction, TH1-9745
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Zhi Shan, Dingkang Fu, Lijie Qiu, Yuling Liang, Chao Huang
المصدر: Buildings, Vol 13, Iss 5, p 1236 (2023)
مصطلحات موضوعية: prefabricated building, component parts, coding method, semi-explicit coding, whole life cycle, Building construction, TH1-9745
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Heping Li, Jie Hu, Lijie Qiu, Yijiang Wu, Baiyin Zhong, Rong Ye, Binhui Xie
المصدر: Anti-Cancer Drugs; Jan2024, Vol. 35 Issue 1, p55-62, 8p
-
4
المؤلفون: Wenyi Mei, Sisi Fan, Yufei Han, Cunjian Shi, Lijie Qiu, Yunheng Shen, Zhenjiang Zhao, Yufang Xu, Honglin Li
المصدر: Organic & Biomolecular Chemistry. 21:1395-1398
مصطلحات موضوعية: Organic Chemistry, Physical and Theoretical Chemistry, Biochemistry
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ce842c6c1984dd2c93cf075126c0d0e4
https://doi.org/10.1039/d3ob00016h -
5
المؤلفون: Lijuan Zhang, Lijie Qiu, Caicai Feng
المصدر: IOP Conference Series: Earth and Environmental Science. 514:032034
مصطلحات موضوعية: Pollution, media_common.quotation_subject, Control (management), Environmental science, Environmental planning, media_common
-
6
المؤلفون: Leqiang Wang, Xueheng Zhou, Yixiang Zhang, Lijie Qiu, Chengpeng Gao, Defeng Hua
المصدر: Oncology Letters
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, efficacy, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, icotinib, medicine, pemetrexed, Survival rate, Lung, business.industry, Cancer, Articles, medicine.disease, lung adenocarcinoma, Molecular medicine, 030104 developmental biology, Pemetrexed, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Icotinib, Adenocarcinoma, business, prognostic survival rate, Progressive disease, medicine.drug